Voya Investment Management LLC Fate Therapeutics Inc Transaction History

Voya Investment Management LLC

$79.9 Billion
Q3 2024

A detailed history of Voya Investment Management LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Voya Investment Management LLC holds 33,434 shares of FATE stock, worth $74,223. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,434

Previous 33,254 0.54%

Holding current value

$74,223

Previous $109,000 7.34%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.12 - $5.57 $561 - $1,002	180 Added 0.54%	33,434 $117,000
Q2 2024 Aug 14, 2024	BUY	$3.26 - $7.08 $17,819 - $38,699	5,466 Added 19.67%	33,254 $109,000
Q1 2024 May 15, 2024	SELL	$3.54 - $8.35 $231,958 - $547,133	-65,525 Reduced 70.22%	27,788 $203,000
Q4 2023 Feb 14, 2024	BUY	$1.65 - $3.94 $18,961 - $45,278	11,492 Added 14.05%	93,313 $348,000
Q3 2023 Nov 14, 2023	BUY	$2.02 - $5.04 $49,742 - $124,110	24,625 Added 43.05%	81,821 $173,000
Q2 2023 Aug 14, 2023	BUY	$4.76 - $6.59 $26,608 - $36,838	5,590 Added 10.83%	57,196 $272,000
Q1 2023 May 15, 2023	BUY	$4.24 - $11.12 $83,294 - $218,452	19,645 Added 61.47%	51,606 $294,000
Q3 2022 Nov 14, 2022	SELL	$21.04 - $36.06 $21,629 - $37,069	-1,028 Reduced 3.12%	31,961 $716,000
Q2 2022 Aug 15, 2022	SELL	$17.78 - $42.39 $1.5 Million - $3.59 Million	-84,606 Reduced 71.95%	32,989 $817,000
Q1 2022 May 16, 2022	BUY	$29.67 - $60.28 $2.54 Million - $5.17 Million	85,733 Added 269.08%	117,595 $4.56 Million
Q4 2021 Feb 14, 2022	SELL	$47.84 - $64.34 $9.95 Million - $13.4 Million	-208,013 Reduced 86.72%	31,862 $1.87 Million
Q3 2021 Nov 15, 2021	BUY	$59.27 - $95.73 $1.81 Million - $2.93 Million	30,588 Added 14.62%	239,875 $14.2 Million
Q2 2021 Aug 16, 2021	SELL	$67.25 - $92.52 $1.98 Million - $2.73 Million	-29,460 Reduced 12.34%	209,287 $18.2 Million
Q1 2021 May 17, 2021	BUY	$72.16 - $117.4 $2.7 Million - $4.39 Million	37,429 Added 18.59%	238,747 $19.7 Million
Q4 2020 Feb 16, 2021	BUY	$38.09 - $100.95 $6.62 Million - $17.6 Million	173,870 Added 633.45%	201,318 $18.3 Million
Q3 2020 Nov 16, 2020	BUY	$30.41 - $40.5 $175,222 - $233,361	5,762 Added 26.57%	27,448 $1.1 Million
Q2 2020 Aug 14, 2020	SELL	$20.21 - $35.23 $171,542 - $299,032	-8,488 Reduced 28.13%	21,686 $744,000
Q1 2020 May 15, 2020	BUY	$17.28 - $31.88 $11,318 - $20,881	655 Added 2.22%	30,174 $670,000
Q4 2019 Feb 14, 2020	BUY	$13.39 - $20.73 $104,160 - $161,258	7,779 Added 35.78%	29,519 $578,000
Q3 2019 Nov 14, 2019	SELL	$15.47 - $22.5 $41,738 - $60,705	-2,698 Reduced 11.04%	21,740 $338,000
Q2 2019 Aug 14, 2019	SELL	$15.61 - $20.44 $10,521 - $13,776	-674 Reduced 2.68%	24,438 $496,000
Q4 2018 Feb 14, 2019	BUY	$11.48 - $16.98 $54,667 - $80,858	4,762 Added 23.4%	25,112 $322,000
Q1 2018 May 15, 2018	SELL	$6.3 - $13.77 $7,452 - $16,289	-1,183 Reduced 5.49%	20,350 $199,000
Q3 2017 Nov 14, 2017	BUY	$2.6 - $4.31 $55,985 - $92,807	21,533	21,533 $85,000

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $215M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Fate Therapeutics Inc Transaction History